RESULTS OF EXAMINATION OF MICRODELETIONS IN THE AZF(YQ) REGION IN MEN WITH REPRODUCTIVE DISORDERS
Authors:
MUDr. Renata Gaillyová; Ph.D. RNDr. Iveta Valášková 1 1; MUDr. Rastislav Beharka 2; prof. MUDr. Dalibor Pacík; CSc. 2; doc. MUDr. Igor Crha; CSc. 3; prof. MUDr. Pavel Ventruba, DrSc. 3
Authors place of work:
‑Oddělení lékařské genetiky LF MU a FN Brno Černopolní 9, 61 00 Brno e-mail: gaillyova@fnbrno. cz
1; Urologická klinika LF MU a FN Brno
2; ‑Gynekologicko-porodnická klinika LF MU a FN Brno
3
Published in the journal:
Urol List 2007; 5(3): 18-21
Summary
The male factor of infertility is the cause of reproductive disorders in approximately 50 % couples, and there is about 50 % of cases in which the cause of male infertility is unknown.
Microdeletions in the AZF (Yp) regions occur in about 4 – 5 % of men with oligospermia and in about 15 – 18 % of men with azoospermia, in approximately 10 % of men with reproductive disorders.
In couples with reproductive failure, genetic counselling and chromosomal analysis in both partners is recommended. Examination of microdeletions in the AZF regions were performed in men with severe oligo or azoospermia.
Between 2000 and 2006, we performed this analysis in 594 men with pathological sperm count and we found microdeletions in 21 men – 3.54 % (range 1.34 – 5.43 %).
Microdeletion has been mostly found in patients with azoospermia, in only 3 men has been found severe oligospermia with maximal sperm count 1.2 million/ml).
Based on our own experience and on relevant literature, we defined more strict indication criteria for the analysis of microdeletions of AZF regions in men. We found positive results only in men with sperm count of less then 2 milions in ml.
Genetic counselling and genetic analysis are a very important component of assisted reproduction. Information about the risk of transmission of a genetic disorders upon the child should be provided before the methods of assisted reproduction are used.
Key words:
reproductive disorders, male factor, microdeletions AZFa,b,c regions Yq, genetic counselling
Zdroje
1. Dohle GR et al. Genetic risk factors in infertile men with severe oligozoospermia and azoospermia. Hum Reprod 2002; 17(1): 13-16.
2. Friel A et al. Molecular detection of Y chromosome microdeletions: an Irish study. Int J Androl 2001; 24(1): 31-36.
3. Harper PS. Practical Genetic Counselling. 6. ed. London: Arnold 2004.
4. Havlovicová M, Semanová E. Genetické poradenství. Neonatol List 2004; 10: 14-15.
5. Hopps CV et al. Detection of sperm in men with Y chromosome microdeletions of the AZFa, AZF b and AZFc regions. Hum Reprod 2003; 18(8): 1660-1665.
6. Kleiman et al. Genetic evaluation of infertile men. Hum Reprod 1999; 14(1): 33-38.
7. Kremer JAM et al. Microdeletions of the Y chromosome and intracytoplasmatic sperm injection: from gene to clinic. Hum Reprod 1997; 14(4): 687-691.
8. Macek M, Vilímová Š, Potužníková Š et al. Využití lékařské genetiky v reprodukční medicíně. čas Lék čes 2002; 141: 28-34.
9. Maurer B, Simoni M. Y chromosome microdeletion screening in infertile men. J Endocrinol Inve 2000; 23(10): 664-670.
10. Nussbaum RI, McIllnes RR, Willard HF. Klinická genetika. 6. ed. Praha: Triton 2001.
11. řeřábek K. Sterilita a opakované potrácení. Mod Gynek Porod 2002; 11(4): 512-524.
12. Sertič J et al. Genetic Markers of Male Infertility: Y Chromosome Microdeletions and Cystic Fibrosis Transmembrane Conductance Gene Mutations. Croat Med J 2001; 42(4): 416-420.
13. van der Ven K et al. Combined cytogenetic and Y chromosome microdeletion screening in males undergiong intracytoplasmatic sperm injection. Mol Hum Reprod 1997; 3(8): 699-704.
Štítky
Paediatric urologist UrologyČlánok vyšiel v časopise
Urological Journal
2007 Číslo 3
Najčítanejšie v tomto čísle
- ERECTILE DYSFUNCTION FOLLOWING RADICAL PROSTATECTOMY
- Dihydrotestosterone and inhibitors of steroid 5α-REDUCTASE
- MALE CONTRACEPTION
- Is testosterone supplementation a potential risk for the prostate gland of an ageing male?